---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-096743"
form_type: "8-K"
ticker: "AIDX"
cik: "0001139685"
company_name: "20/20 Biolabs, Inc."
filed_at: "2026-09-02T20:32:39+00:00"
generated_at: "2026-09-02T20:34:13.537710+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# 20/20 Biolabs furnishes Sept 2026 investor presentation; no financial detail disclosed

## Summary
- 20/20 Biolabs (AIDX) furnished an investor presentation, dated September 2026, for use in a Sept 2, 2026 investor webinar.
- Presentation text included in the exhibit contains only a cover slide; no revenue, EPS, pipeline, or guidance figures were provided.
- CEO Jonathan Cohen signed the 8-K; no operational or financial updates were disclosed in the filing body or exhibit.
- Material news content could not be extracted from the available exhibit text.

## SEC filing metadata
- accession: 0001213900-26-096743
- form_type: 8-K
- ticker: AIDX
- cik: 0001139685
- company_name: 20/20 Biolabs, Inc.
- filed_at: 2026-09-02T20:32:39+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1139685/000121390026096743/0001213900-26-096743-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1139685/000121390026096743/ea0304455-8k_2020bio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-096743
- JSON: https://secwatch.observer/filing/0001213900-26-096743.json
- Plain text: https://secwatch.observer/filing/0001213900-26-096743.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.